Catalyst Wire Dossier Catalyst Wire Dossier

Fimasartan/Amlodipine/Rosuvastatin fixed-dose combination

fimasartan; amlodipine; rosuvastatin · Boryung Pharmaceutical Co., Ltd.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Fimasartan/Amlodipine/Rosuvastatin fixed-dose combination, covering 2017-08-10 to 2017-08-10. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Compare the Pharmacokinetics and Safety of a Fixed Dose Combination of Fimasartan/Amlodipine/Rosuvastatin [Phase 1]

See pricing